A leading University NHS Foundation Trust, based in the UK, is the study sponsor for a multi-site randomized 1-year evaluation of a pharmaceutical treatment for patients with cardiomyopathy.
Extended Holter Monitoring
A specialist healthtech company headquartered in Ukraine, who successfully developed a leading, cloud-based AI analysis platform, sought to expand their business model. Their goal was to create an end-to-end remote holter monitoring service for hospitals and clinics by incorporating clinical-grade wireless ECG devices.
In 2016, LifeSignals partnered with a company based in Kerala, India that is transforming the way ambulatory cardiac monitoring is delivered and become the new normal among the leading cardiologists and neurologists in hospitals across the country.
A telehealth and cardiac screening company headquartered in Manila has been working with LifeSignals as of early 2020 to expand remote cardiac monitoring in the Philippines.